Aqua Bio Technology (ABTEC) Stock Overview
Engages in the manufacture and sale of ingredients for cosmetic industry in Norway. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ABTEC Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Aqua Bio Technology ASA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 1.08 |
| 52 Week High | NOK 3.99 |
| 52 Week Low | NOK 0.46 |
| Beta | 0.76 |
| 1 Month Change | 20.13% |
| 3 Month Change | 45.95% |
| 1 Year Change | -69.05% |
| 3 Year Change | -86.70% |
| 5 Year Change | -78.14% |
| Change since IPO | -99.38% |
Recent News & Updates
Aqua Bio Technology ASA (OB:ABTEC) Stock's 54% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 21
Aqua Bio Technology ASA (OB:ABTEC) Stock Rockets 40% But Many Are Still Ignoring The Company
May 07Recent updates
Aqua Bio Technology ASA (OB:ABTEC) Stock's 54% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Jun 21Aqua Bio Technology ASA (OB:ABTEC) Stock Rockets 40% But Many Are Still Ignoring The Company
May 07The Director of Aqua Bio Technology ASA (OB:ABT), Roger Hofseth, Just Bought A Few More Shares
Jan 20Have Insiders Been Buying Aqua Bio Technology ASA (OB:ABT) Shares?
Dec 30
Shareholder Returns
| ABTEC | NO Chemicals | NO Market | |
|---|---|---|---|
| 7D | 3.8% | 1.5% | -0.03% |
| 1Y | -69.1% | 21.0% | 6.9% |
Return vs Industry: ABTEC underperformed the Norwegian Chemicals industry which returned 21% over the past year.
Return vs Market: ABTEC underperformed the Norwegian Market which returned 6.9% over the past year.
Price Volatility
| ABTEC volatility | |
|---|---|
| ABTEC Average Weekly Movement | 47.9% |
| Chemicals Industry Average Movement | 5.5% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in NO Market | 13.7% |
| 10% least volatile stocks in NO Market | 3.0% |
Stable Share Price: ABTEC's share price has been volatile over the past 3 months compared to the Norwegian market.
Volatility Over Time: ABTEC's weekly volatility has increased from 31% to 48% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 37 | Fredrik Henriksen | aquabiotechnology.com |
Aqua Bio Technology ASA engages in the manufacture and sale of ingredients for cosmetic industry in Norway. It offers Aquabeautine XL, a proprietary ingredient for skincare products; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use. The company distributes its products through Internet, stores, and skincare clinics.
Aqua Bio Technology ASA Fundamentals Summary
| ABTEC fundamental statistics | |
|---|---|
| Market cap | NOK 117.55m |
| Earnings (TTM) | -NOK 337.35m |
| Revenue (TTM) | NOK 107.17m |
Is ABTEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABTEC income statement (TTM) | |
|---|---|
| Revenue | NOK 107.17m |
| Cost of Revenue | NOK 104.54m |
| Gross Profit | NOK 2.63m |
| Other Expenses | NOK 339.98m |
| Earnings | -NOK 337.35m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
Aug 27, 2025
| Earnings per share (EPS) | -3.10 |
| Gross Margin | 2.45% |
| Net Profit Margin | -314.78% |
| Debt/Equity Ratio | -177.3% |
How did ABTEC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/07/15 23:44 |
| End of Day Share Price | 2025/07/15 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aqua Bio Technology ASA is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tomas Skeivys | Norne Securities AS |